Recent Research Advances in Small-Molecule Pan-PIM Inhibitors

Abstract: PIM kinase is consequently emerging as a promising target for cancer therapeutics and immunomodulation. PIM kinases are overexpressed in a variety of hematological malignancies and solid tumors, and their inhibition has become a strong therapeutic interest. Currently, some pan-PIM kinase inhibitors are being developed under different phases of clinical trials. Based on the different scaffold structures, they can be classified into various subclasses. The X-ray structure of the kinase complex outlines the rationale of hit compound confirmation in the early stage. Structure–activity relationships allow us to rationally explore chemical space and further optimize multiple physicochemical and biological properties. This review focuses on the discovery and development of small-molecule pan-PIM kinase inhibitors in the current research, and hopes to provide guidance for future exploration of the inhibitors.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Recent Research Advances in Small-Molecule Pan-PIM Inhibitors ; volume:04 ; number:04 ; year:2022 ; pages:e207-e222
Pharmaceutical fronts ; 04, Heft 04 (2022), e207-e222

Beteiligte Personen und Organisationen
Xu, Lei
Meng, Yu-Cheng
Guo, Peng
Li, Ming
Shao, Lei
Huang, Jun-Hai

DOI
10.1055/s-0042-1758692
URN
urn:nbn:de:101:1-2023020911302495273006
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:48 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

  • Xu, Lei
  • Meng, Yu-Cheng
  • Guo, Peng
  • Li, Ming
  • Shao, Lei
  • Huang, Jun-Hai

Ähnliche Objekte (12)